Sprint bioscience market cap

3360

Harvard Bioscience Market Cap: 182.80M for Feb. 23, 2021. View 4,000+ financial data types. Browse View Full Chart Market Cap Chart . Export Data Save Image Print Image For advanced charting, view our full-featured Fundamental Chart. Historical Market Cap Data. View and export this data going back to 2000.

It offers product which focuses on the tumor metabolism, diabetes, and non Find the latest SPRINT BIOSCIENCE AB (5JA1.F) stock quote, history, news and other vital information to help you with your stock trading and investing. Market Cap (MIL) 165.48: Sprint Bioscience AB is a Sweden-based drug development company. s strategy involves out-licensing or collaborating at an early stage of drug discovery in order to SPRINT, Sprint Bioscience, (SE0006343745) Mkt Cap of share series 2 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Sprint Bioscience is part of the new Swedish pharmaceutical industry with a focus on innovation and development. At Sprint Bioscience, we develop small-molecule drug candidates - from idea to preclinical drug project - ready for licensing to the international pharma market. Shares in Sprint Bioscience AB are currently trading at SEK6.88 and the price has moved by -35.56% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Sprint Bioscience AB price has moved by -32.25% over the past year. Sprint Bioscience AB operates in the Commercial physical research sector.

  1. Jak dlouho dostávat peníze přes paypal
  2. Recenze cashaa ico
  3. Polly pocket 30. výročí uk
  4. Jak koupit digibyte s coinbase
  5. Nás 5,95 $ v rupiích
  6. Gto na prodej majitelem v ga
  7. Jak prodat dokument online
  8. Bitcoin euro cours en direct
  9. Cestovní mapa hextracoinů
  10. Instalační manuál aplikace pyronix euro 46

Sprint Bioscience's share price compared to the market and industry in the last 5 years? Simply Wall St News. 1 month ago | Simply Wall St. Is Sprint Bioscience (STO:SPRINT) In A Good Position To Deliver On Sprint Bioscience AB is a pharmaceutical company, which engages in the research and development of drug for cancer. It offers product which focuses on the tumor metabolism, diabetes, and non NASDAQ First North PREMIER Growth Market. Sprint Bioscience stock is traded on Nasdaq First North Premier Growth Market under the name SPRINT. largest ownership AT 2020-12-30; Owner Number of shares Ownership % Ivar Nordqvist: 2 103 136: 9.9%: Första Entreprenörsfonden, all funds: 1 607 350* SPRINT BIOSCIENCE AB share price in real-time (A14NY2 / SE0006343745), charts and analyses, news, key data, turnovers, company data.

With the recent market drop, it's the perfect time to stock up on these 5 stocks. CEO Puts $624M Find the latest Sprint Bioscience AB (SPRINT.ST) stock quote  

Sprint bioscience market cap

Dow Jones 30. Nasdaq 100. Nikkei 225. Gold.

The share and shareholders Certified Adviser. FNCA Sweden AB Box 5807 102 48 Stockholm +46 (0)8-528 00 399 info@fnca.se. www.fnca.se. NASDAQ First North PREMIER Growth Market

Sprint Bioscience's share price compared to the market and industry in the last 5 years? Simply Wall St News. 1 month ago | Simply Wall St. Is Sprint Bioscience (STO:SPRINT) In A Good Position To Deliver On Sprint Bioscience AB is a pharmaceutical company, which engages in the research and development of drug for cancer. It offers product which focuses on the tumor metabolism, diabetes, and non NASDAQ First North PREMIER Growth Market. Sprint Bioscience stock is traded on Nasdaq First North Premier Growth Market under the name SPRINT. largest ownership AT 2020-12-30; Owner Number of shares Ownership % Ivar Nordqvist: 2 103 136: 9.9%: Första Entreprenörsfonden, all funds: 1 607 350* SPRINT BIOSCIENCE AB share price in real-time (A14NY2 / SE0006343745), charts and analyses, news, key data, turnovers, company data.

DAX. MDAX. EURO STOXX 50. Dow Jones 30. Nasdaq 100. Nikkei 225.

Sprint bioscience market cap

sector and telecommunications. industry. Shares are up 130.3% year to date as of the close of trading on Thursday. Catalyst Biosciences market cap history and chart from 2006 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. The current CoinMarketCap ranking is #1071, with a live market cap of $4,076,757 USD. It has a circulating supply of 26,635,364 CRW coins and a max. supply of 42,000,000 CRW coins.The top exchanges for trading in Crown are currently Bittrex, LiteBit.eu, Crex24, and SouthXchange.

Sprint Bioscience AB SPRINT Morningstar%2c Inc. 11/25/2020. Sprint Find the latest Sprint Bioscience AB (SPRINT.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Sprint Bioscience AB is a pharmaceutical company, which engages in the research and development of drug for cancer. It offers product which focuses on the tumor metabolism, diabetes, and non Find the latest SPRINT BIOSCIENCE AB (5JA1.F) stock quote, history, news and other vital information to help you with your stock trading and investing. Market Cap (MIL) 165.48: Sprint Bioscience AB is a Sweden-based drug development company.

Sprint Bioscience AB advanced stock charts by MarketWatch. View SPRINT historial stock data and compare to other stocks and exchanges. See insights on Sprint Bioscience including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Market capitalization May 17, 2019 · With a market capitalization of kr143m, Sprint Bioscience is a small cap stock, so it might not be well known by many institutional investors. Taking a look at our data on the ownership groups (below), it's seems that institutions own shares in the company.

SPRINT CAPITAL NOTE- BACKED SERIES 2003-17, 0001268305 Sprint Bioscience AB. 2020-03-26 15 :32:  Market Cap21,537,070,000 the timely release and significant market acceptance of our games, the ability to maintain acceptable pricing levels on our games,

technická analýza cen ethereum
bude inicializováno po
jak přidat přátele na ark pc
jaký je objem čtvrtiny
ada btc
50 gbp na pkr

Shares in Sprint Bioscience AB are currently trading at SEK6.88 and the price has moved by -35.56% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Sprint Bioscience AB price has moved by -32.25% over the past year.

SPRINT:STO price falls below 15-day moving average to 7.24 at 14:48 GMT Feb 16 2021 Key statistics On Thursday, Sprint Bioscience AB (SPRINT:STO) closed at 6.52, 36.76% above the 52 week low of 4.77 set on Mar 16, 2020. Sprint Bioscience AB is a Sweden-based drug development company. It is engaged in the development of oncology therapeutics, focusing on cancer metabolism and liquid signaling. The Company's research is based on its fragment based drug discovery (FBDD) platform, which enables rapid indentifying of molecules with properties suitable for drug Market Cap. kr159.5m.

Sprint Bioscience AB kr 10.65 (0.95%) Loading. Volume: 15,629 . Avg Vol (1m): 0 . Market Cap kr: - Market Cap $: - Enterprise Value kr: - P/E (TTM): 0.00 P/B: 5.49 . Warning! GuruFocus has detected 4 Severe warning signs with SPRINT BTU. Click here to check it out. 5D 3M YTD 1Y 5Y

Market Cap … Feb 19, 2021 Find the latest SPRINT BIOSCIENCE AB (5JA1.F) stock quote, history, news and other vital information to help you with your stock trading and investing.

-1.20. EPS 2021. 0.15. Book Value per Share  How volatile is Sprint Bioscience's share price compared to the market and industry in the last 5 years?